ReviewTherapeutics and clinical risk management2023

Clinical Utility of Deutetrabenazine as a Treatment Option for Chorea Associated with Huntington's Disease and Tardive Dyskinesia.

Samuel Frank et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.